FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387549004: Cinoxacin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461727019 Cinoxacin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481639010 Cinoxacin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
369211000195118 cinoxacina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
800981000172118 cinoxacine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
2335201000195110 Cinoxacin de Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cinoxacin (substance) Is a Quinolone antibacterial true Inferred relationship Some
Cinoxacin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Cinoxacin adverse reaction Causative agent (attribute) True Cinoxacin (substance) Inferred relationship Some 1
Allergy to cinoxacin (finding) Causative agent (attribute) False Cinoxacin (substance) Inferred relationship Some
Cinoxacin 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cinoxacin (substance) Inferred relationship Some
Product containing precisely cinoxacin 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cinoxacin (substance) Inferred relationship Some
Product containing cinoxacin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cinoxacin (substance) Inferred relationship Some 1
Allergy to cinoxacin (finding) Causative agent (attribute) True Cinoxacin (substance) Inferred relationship Some 1
Cinoxacin 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cinoxacin (substance) Inferred relationship Some 1
Cinoxacin 250 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cinoxacin (substance) Inferred relationship Some 1
Product containing precisely cinoxacin 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cinoxacin (substance) Inferred relationship Some 1
Product containing precisely cinoxacin 500 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cinoxacin (substance) Inferred relationship Some 1
Cinoxacin 250 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cinoxacin (substance) Inferred relationship Some 1
Product containing precisely cinoxacin 500 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cinoxacin (substance) Inferred relationship Some 1
Product containing cinoxacin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cinoxacin (substance) Inferred relationship Some 1
Product containing only cinoxacin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cinoxacin (substance) Inferred relationship Some 1
Cinoxacin only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cinoxacin (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

Back to Start